As part of its policy activity, the Society has issued several position statements on issues relevant to the molecular biosciences and the broader science sector.These statements outline the Society's stance on these important topics and underscore activity and engagement across the community.One issue that remains integral to the Society's charitable mission is that of equity, diversity and inclusion (EDI) in the molecular biosciences.Collaboratively between the EDI Advisory Panel and Policy Advisory Panel, drawing on both panels' expertise, the Society has updated its EDI position statement to outline its activities and ambitions in the EDI space, while recognizing there is much work still to do to achieve the goal of an equitable, diverse, and inclusive bioscience sector.The full statement is shared here.
No takes yet. Share an insight, caveat, or question.
Lappin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: